DE60207409D1 - Hiv1-vpr-wechselwirkungen mit dem mitochondrialen apoptosis-induzierenden faktor sowie verfahren zur verwendung davon - Google Patents

Hiv1-vpr-wechselwirkungen mit dem mitochondrialen apoptosis-induzierenden faktor sowie verfahren zur verwendung davon

Info

Publication number
DE60207409D1
DE60207409D1 DE60207409T DE60207409T DE60207409D1 DE 60207409 D1 DE60207409 D1 DE 60207409D1 DE 60207409 T DE60207409 T DE 60207409T DE 60207409 T DE60207409 T DE 60207409T DE 60207409 D1 DE60207409 D1 DE 60207409D1
Authority
DE
Germany
Prior art keywords
vpr
hiv1
interactions
mitochondrial apoptosis
inductive factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60207409T
Other languages
English (en)
Other versions
DE60207409T2 (de
Inventor
B Weiner
Karuppiah Muthumani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Application granted granted Critical
Publication of DE60207409D1 publication Critical patent/DE60207409D1/de
Publication of DE60207409T2 publication Critical patent/DE60207409T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/163—Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60207409T 2001-05-25 2002-05-28 Hiv1-vpr-wechselwirkungen mit dem mitochondrialen apoptosis-induzierenden faktor sowie verfahren zur verwendung davon Expired - Fee Related DE60207409T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29357001P 2001-05-25 2001-05-25
US293570P 2001-05-25
PCT/US2002/016731 WO2003040415A1 (en) 2001-05-25 2002-05-28 Hiv-1 vpr interactions with mitochondrial apoptosis inducing factor and methods of using the same

Publications (2)

Publication Number Publication Date
DE60207409D1 true DE60207409D1 (de) 2005-12-22
DE60207409T2 DE60207409T2 (de) 2006-07-20

Family

ID=23129615

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60207409T Expired - Fee Related DE60207409T2 (de) 2001-05-25 2002-05-28 Hiv1-vpr-wechselwirkungen mit dem mitochondrialen apoptosis-induzierenden faktor sowie verfahren zur verwendung davon

Country Status (10)

Country Link
US (1) US7598041B2 (de)
EP (1) EP1397520B1 (de)
JP (1) JP2005508506A (de)
AT (1) ATE310104T1 (de)
AU (1) AU2002310158B2 (de)
CA (1) CA2448162A1 (de)
DE (1) DE60207409T2 (de)
DK (1) DK1397520T3 (de)
ES (1) ES2251596T3 (de)
WO (1) WO2003040415A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108707A (en) 1993-02-19 1999-06-20 Weiner David B Pharmaceutical compositions and diagnostic kits containing RPH protein or RPV-binding proteins
US5780220A (en) 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5976786A (en) * 1995-12-29 1999-11-02 National Jewish Medical And Research Center Screening methods for the identification of compounds that modulate apoptosis in immunodeficiency virus infected cells
US6060587A (en) * 1996-01-29 2000-05-09 The Trustees Of The University Of Pennsylvania Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
AU6435598A (en) * 1997-02-11 1998-08-26 Regents Of The University Of California, The Identifying agents for treating lentiviral infection

Also Published As

Publication number Publication date
CA2448162A1 (en) 2003-05-15
US7598041B2 (en) 2009-10-06
DE60207409T2 (de) 2006-07-20
US20050026138A1 (en) 2005-02-03
WO2003040415A1 (en) 2003-05-15
EP1397520A1 (de) 2004-03-17
EP1397520A4 (de) 2004-07-28
JP2005508506A (ja) 2005-03-31
ES2251596T3 (es) 2006-05-01
DK1397520T3 (da) 2006-03-27
AU2002310158B2 (en) 2007-06-28
EP1397520B1 (de) 2005-11-16
ATE310104T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DE60134764D1 (de) VERWENDUNG VON MoO3 ALS KORROSIONSINHIBITOR SOWIE EINEN SOLCHEN INHIBITOR ENTHALTENDE BESCHICHTUNGSZUSAMMENSETZUNG
DE50108593D1 (de) Vorrichtung und Verfahren zur Messung der Dicke und Unrundheit von länglichen Werkstücken
ATE458191T1 (de) Verfahren zur selektion von partikeln
DE60135029D1 (de) Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis
DE60140156D1 (de) Verfahren zur Erneuerung von Diffusionsschichten auf Superlegierungen
DE60205157D1 (de) Verfahren zum Nachweis von Fluoreszenz in Anwesenheit von Umgebungslicht
AU2002250138A1 (en) Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens
DE69809575D1 (de) Verfahren und zusammensetzung zur inhibierung der verstopfung von rohrleitungen durch gashydraten
DE60126077D1 (de) Verfahren zur hochdurchsatzprofilierung neuer werkstoffe
ATE192776T1 (de) Verwendung von fluoreszierenden markierungsmitteln für petroleum- produkte
DE60224275D1 (de) Moleküle und verfahren zur inhibierung der freisetzung von kim-1
DE60002182T2 (de) Verfahren zur entsalzung von röhöl
DE69911654D1 (de) Verfahren zur verringerung des metallgehalts von erdölströmen
DE59809414D1 (de) Verfahren und Produkt zur Verbesserung der Kalfflie DOLLAR eigenschaften von Brennstoffölen
ATE320475T1 (de) Gesichertes haftendes flüssiges produkt oder beschichtung, die optisch entwickelbar ist, verfahren zur markierung von produkten mit einer flüssigen tinte und verwendung von diesem produkt
DE50105968D1 (de) VERFAHREN ZUR HERSTELLUNG VON AlKYLVERBRÜCKTEN LIGANDSYSTEMEN UND ÜBERGANGSMETALLVERBINDUNGEN
DE69904156D1 (de) Verfahren zur inhibierung der ablagerung von weisspech in der papierherstellung
DE60231466D1 (de) Verfahren zur Wiederherstellung von Diffusions-Aluminid-Beschichtung
DE69923734D1 (de) Verfahren und Vorrichtung zur Messung der Dicke von transparenten Materialien
DE60207409D1 (de) Hiv1-vpr-wechselwirkungen mit dem mitochondrialen apoptosis-induzierenden faktor sowie verfahren zur verwendung davon
DE60040960D1 (de) Verfahren und Vorrichtung zur Dickenmessung von durchsichtigen Filmen
DE59806380D1 (de) Verfahren zur Abstandsmessung und Durchführung des Verfahrens
DE60232169D1 (de) System und verfahren zur verminderung der dicke einer papierbahn
ATE394360T1 (de) Verfahren zur verminderung von von der verwendung von fluorphosphitkatalysatoren herruehrenden fluoridverunreinigungen
DE59007079D1 (de) (meth)acrylat-copolymerisate sowie ihre verwendung in der nichtlinearen optik und zur herstellung von langmuir-blodgett-schichten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee